Fill Finish Manufacturing Industry Leaders Becton, Dickinson and Company West Pharmaceutical Services, Inc IMA S.P.A Syntegon Technology GmbH Stevanato Group *Disclaimer: Major Players sorted in no particular order Recent Industry Developments October 2025: Jubilant HollisterStier launched a third sterile fill-finish line at Spokane, Washington, adding 250 million dose capacity and 25 new SKUs to its CDMO offering
Monitoring your progress at home Maximus provides physician oversight, but you are the one living in your body every day
[Ref] Other Very common (10% or more): Pain (35%), flu syndrome (29%), chest pain (15%), accidental injury (12%), asthenia (12%), fever (12%) Common (1% to 10%): Peripheral edema, weight decrease, weight increase Very rare (less than 0.01%): Body odor, International Normalized Ratio (INR) increased [Ref] Local Very common (10% or more): Injection site reaction (38%) [Ref] Musculoskeletal Musculoskeletal side effects, in chronic hemodialysis patients, for levocarnitine (the active ingredient contained in L-Carnitine) in relation to placebo therapy have included asthenia (8% to 12% vs 8%) and leg cramps (4% to 8% vs 13%)
Previous reviews (15) first proposed that GLP-1 and GLP-1 receptor agonists (GLP-1RAs) may modulate taste perception, especially for sweet stimuli
